» Articles » PMID: 18548615

Insulin Loaded PLGA Microspheres: Effect of Zinc Salts on Encapsulation, Release, and Stability

Overview
Journal J Pharm Sci
Publisher Elsevier
Specialties Pharmacology
Pharmacy
Date 2008 Jun 13
PMID 18548615
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, zinc carbonate, and zinc acetate) on insulin encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres. Microspheres were prepared by water-in-oil-in-water (w/o/w) double emulsion solvent evaporation technique and characterized. Integrity of the encapsulated insulin and stability of the released insulin was assessed using a wide range of comprehensive analytical techniques. The EE of the formulation prepared without the addition of a zinc salt was 69%, the secondary structure of the encapsulated insulin in this formulation was found to be altered. Further, desamido insulin and aggregates were observed during in vitro release. When insulin was encapsulated with a zinc salt, EE increased significantly, secondary structure was unaltered, and no degradation or aggregation products were found. Initial burst release and release kinetics were markedly changed with the addition of zinc salts. More than 87% of the encapsulated insulin was released over a 2-week period with the addition of a zinc salt. In conclusion, zinc salts can be useful to increase the EE and stability of insulin in PLGA microspheres prepared by w/o/w technique.

Citing Articles

Zinc in Dermatology: Exploring Its Emerging Role in Enhancing Botulinum Toxin Formulations and Clinical Efficacy.

Foster L, Foppiani J, Xun H, Lee D, Utz B, Hernandez Alvarez A Curr Issues Mol Biol. 2024; 46(11):12088-12098.

PMID: 39590311 PMC: 11593192. DOI: 10.3390/cimb46110717.


In Vitro and In Vivo Evaluations of Berberine-Loaded Microparticles Filled In-House 3D Printed Hollow Capsular Device for Improved Oral Bioavailability.

Choudhury D, Jala A, Murty U, Borkar R, Banerjee S AAPS PharmSciTech. 2022; 23(4):89.

PMID: 35296955 PMC: 8926385. DOI: 10.1208/s12249-022-02241-9.


Development, Optimization, and Pharmacokinetics Study of Bufalin/Nintedanib Co-loaded Modified Albumin Sub-microparticles Fabricated by Coaxial Electrostatic Spray Technology.

Chen P, Lu S, Pan B, Xu Y AAPS PharmSciTech. 2021; 23(1):13.

PMID: 34888752 DOI: 10.1208/s12249-021-02163-y.


Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment.

Li C, Wan L, Luo J, Jiang M, Wang K Int J Nanomedicine. 2021; 16:1261-1280.

PMID: 33628020 PMC: 7898203. DOI: 10.2147/IJN.S283416.


Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part I: Biomaterials-Based Drug Delivery Devices.

Jemni-Damer N, Guedan-Duran A, Fuentes-Andion M, Serrano-Bengoechea N, Alfageme-Lopez N, Armada-Maresca F Front Bioeng Biotechnol. 2020; 8:549089.

PMID: 33224926 PMC: 7670958. DOI: 10.3389/fbioe.2020.549089.